Currys Share Buybacks Signal Undervaluation Amid Operational Turnaround and Raising Profit Guidance

Currys' capital return programme is a disciplined, if modest, signal of confidence. The company has a £50 million share buyback authority approved by shareholders last September. To date, it has spent £30 million of that, executing purchases that have cancelled 247,889 shares on 20 March and 426,671 shares on 2 March. These are the latest in a series of cancellations, including a smaller one on 16 March. The total impact on the share count is real but incremental, a steady reduction in the denominator for earnings per share.

The consensus view from analysts leans positive. The most recent rating is a Buy with a £179.00 price target, with a similar Buy rating and £180 price target cited elsewhere. This implies meaningful upside from recent trading levels, suggesting the market is not fully pricing in the company's improving fundamentals, such as better growth and reduced leverage.

Yet there is a clear disconnect. Despite these buybacks and the bullish analyst stance, the stock price has declined. The cancellations occurred at prices around 135-156p, levels that reflect a market sentiment pricing in other headwinds or skepticism. This creates an asymmetry: the company is using capital to return value at what appears to be a depressed price, while the broader market seems to be looking past the operational improvements. The buyback, in this light, is a tactical move that may not move the needle for the stock until the underlying sentiment shifts.

Financial Reality vs. The Expectations Gap

The buyback is not a reaction to weakness; it is a tool to enhance value amid a clear operational turnaround. The financial reality on the ground is one of acceleration and improving profitability. In the 17 weeks to August, UK & Ireland like-for-like sales grew 3%, accelerating from the prior year. This momentum continued into the peak holiday period, where UK & Irish LFL sales rose 3% and the Nordics saw a standout 12% increase. The growth is broad-based, supported by strong demand in AI computing, large appliances, and recurring services, with credit adoption hitting 25%.

This operational strength is translating directly into the bottom line. The company has raised its profit guidance, now expecting adjusted profit before tax of £180-190m for the year. That forecast is explicitly ahead of consensus expectations, a clear beat on the street's prior view. The path to this improvement is disciplined: the company is focusing on more profitable categories, maintaining gross margin discipline, and seeing a sharp reduction in its pension deficit, which will cut annual contributions from £78 million to just £13 million starting next year.

Crucially, the company is in a strong financial position to fund this capital return. It entered the year with £184 million net cash and expects to finish with at least £100 million net cash, even after funding operations, dividends, and the £50 million buyback. This net cash buffer provides a robust safety net and confirms the buyback is a discretionary, value-enhancing move, not a necessity.

The disconnect, then, is not with the fundamentals but with the market's sentiment. The buyback is being executed at prices that appear to ignore this improving trajectory. The cancellations happened at levels that reflect a market pricing in other concerns, perhaps lingering worries about consumer spending or the pace of the Nordics recovery. The company, by contrast, is acting on a clearer view of its own improving cash flow and profitability. This creates the asymmetry: the firm is using its strong balance sheet to buy shares at what it sees as a discount, while the market's broader view remains cautious.

Valuation and the Risk/Reward Asymmetry

The buyback's direct financial impact is clear but modest. By cancelling shares, the company reduces the total number outstanding, which mathematically boosts earnings per share. The latest cancellations have brought the total share count down to around 1.1 billion. However, the absolute reduction in shares is a small fraction of the company's total market capitalization. The £50 million buyback authority is a discretionary capital return, not a transformative event for the share count. The real EPS benefit will be incremental, not a game-changer.

The key risk is opportunity cost. The programme consumes cash that could be deployed for higher-return investments if new growth opportunities arise. While the company is in a strong net cash position, committing capital to buybacks at current prices locks in a return based on today's valuation. If the operational turnaround accelerates faster than expected, that cash might have been better used to fund expansion or acquisitions. The buyback, therefore, represents a bet that the stock is undervalued relative to its cash-generating potential.

Analyst sentiment remains positive, with a consensus Buy rating and a price target near £180. This implies upside from recent trading levels, suggesting the market is not fully pricing in the company's improved trajectory. Yet this is a consensus view that may already be reflected in the stock. The recent price decline, even as buybacks occur, indicates that broader market sentiment is still cautious, possibly pricing in other headwinds. The asymmetry here is that management is acting on its superior view of the balance sheet and cash flow, while the market's view remains more skeptical. For the buyback to move the needle, the market's sentiment needs to catch up to the improving fundamentals.

Catalysts and What to Watch

The buyback thesis hinges on near-term events that will confirm whether management's confidence in the balance sheet is justified or if the market's caution is warranted. Three key metrics will serve as the litmus test.

First, monitor the pace of the £50 million programme against the stock's price. The buyback is scheduled to end by 30 April 2026, leaving roughly a month to execute. The company has already spent £30 million, cancelling shares at prices around 135-156p. The critical signal will be whether management continues to deploy the remaining capital at these levels or if it pauses or accelerates based on price action. A disciplined, full-scale execution at current prices would be a strong vote of confidence in the valuation. Any deviation, such as a significant slowdown, could signal that management sees better value elsewhere or is concerned about the stock's trajectory.

Second, track the full-year results for confirmation that the raised guidance is met. The company expects adjusted profit before tax of £180-190m, explicitly ahead of consensus. This forecast is the operational bedrock for the capital return. Meeting or exceeding this target would validate the turnaround narrative and the financial flexibility that makes the buyback possible. A miss, however, would undermine the entire premise, suggesting that the margin improvements and cost savings are not as durable as projected. The results, due later this year, are the ultimate proof point.

Finally, watch for any change in the capital return strategy. The company has provided a clear framework: a £100 million net cash target and the anticipated fall in annual pension contributions from £78 million to £13 million starting next year. These are not one-off events but structural improvements that free up cash flow. The market's cautious sentiment may persist if it sees these savings as already priced in or if it questions their sustainability. Any indication that the company plans to increase the buyback beyond the current £50 million authority, or to shift capital to other uses, will signal a change in the capital allocation outlook. For now, the strategy appears set, but the market will be watching for any shift in tone or commitment.

The bottom line is that the buyback is a tactical move, not a catalyst in itself. The real catalysts are the operational results and the disciplined execution of the capital return plan. If the company hits its profit target and completes the buyback at today's prices, the stock's recent decline may look like a temporary mispricing. If the results disappoint or the buyback stalls, the market's skepticism could be validated.